Funding Opportunities

[ LSOs | Intramural Awards | Foundations/Other | NIH Announcements ]

Intramural Funding Opportunities

For questions about intramural awards, please contact Meredith Donnelly.

• Deadline: Feb 28, 2025
  Laboratory for Genomics Research (LGR) Innovation Awards Program
  This program aims to support early-stage technology development projects that could mature into future UC-LGR collaborative projects. Innovation Awards are one-year research grants to support labs at the UCSF and UC Berkeley campuses with an interest in developing highly innovative ideas into early proofs of concept across the field of functional genomics and CRISPR/Cas-based tool development.
  Deadline: March 3, 2025
  UCSF RAP Spring Cycle 2025
  The UCSF Resource Allocation Program (RAP) offers a single online application process for a variety of intramural grants.
• Deadline: March 10, 2025
  HDFCCC Sarcoma Research Hub RFA
  The Sarcoma Research Hub is requesting applications from HDFCCC members for pilot research projects. Priority areas to be funded include: research strategic goals of the Sarcoma Program (see RFA for details), cross-disciplinary research and investigators who have not previously collaborated, and projects addressing health disparities.
• Deadline: March 14, 2025
  HDFCCC Neurologic Oncology Program RFA
  The Neurologic Oncology Program is requesting applications from program members for pilot research projects. Priority areas to be funded include: research addressing aims of the Neurologic Oncology Program (see RFA for details), cross-disciplinary research and investigators who have not previously collaborated, and projects addressing health disparities.
• Deadline: March 28, 2025
  HDFCCC Cancer Control Program RFA
  The Cancer Control Program is requesting applications from active program members, or postdocs of program members, for pilot research projects. Priority areas to be funded include: research addressing aims of the Cancer Control Program (see RFA for details), cross-disciplinary research and investigators who have not previously collaborated, and projects addressing health disparities.
• Deadline: March 31, 2025
  HDFCCC Pediatric Malignancies Program RFA
  The Pediatric Malignancies Program is requesting applications from Program members for pilot research projects. Projects must include a new collaboration with an investigator at UCSF.
• Deadline: March 31, 2025
  CRISPR Cures for Cancer RFA
  The CRISPR Cures for Cancer Initiative -- a program uniting researchers at UCSF, Gladstone Institutes, and UC Berkeley / Innovative Genomics Institute -- requests proposals that support our vision of a future of precise, genetically engineered, immune cell therapies accessible to patients across the full range of human cancers. We seek proposals for high-risk, high-reward projects developing or applying genomic technologies to the understanding and treatment of human cancer using next-generation cell-based therapies.
• Deadline: April 25, 2025
  HDFCCC Molecular Oncology Program Core Facilities Pilot RFA
  The Molecular Oncology Program is requesting applications from active Molecular Oncology Program members for Core Facilities Pilot Awards. Awards will support pilot projects utilizing one or more HDFCCC Core Facilities including Biostatistics, Imaging, Computational Biology, Laboratory for Cellular Analysis, Preclinical Therapeutics, Small Molecule Discovery, Tobacco and Carcinogen Biomarkers.  

Foundations/Other Sources

• Deadline: March 15, 2025
  Arc Institute Innovation Investigator Program
  This year’s Arc Institute Innovation Investigator Program has been announced, with focus areas in Immunology, Neurobiology, and Machine Learning. Chosen investigators will receive $1,000,000 direct costs in unrestricted funding from the Arc Institute over 5 years and gain access to Arc resources and facilities, including the opportunity to collaborate with Technology Centers and to use Arc scientific core facilities, while maintaining their UCSF lab and position at their home university. (UCSF applicants, please email [email protected] to announce your intention to apply, then follow application instructions in RFP, conferring with your Grants Officer as needed.)
• Extended Deadline: March 18, 2025
  NCCN and Taiho Non-Small Cell Lung Cancer Research Grant Opportunity
  National Comprehensive Cancer Network® (NCCN®) is pleased to announce a collaboration with Taiho Oncology, Inc., to support NCCN Member Institution faculty for the performance of clinical studies to further evaluate the effectiveness of zipalertinib in the treatment of Non-Small Cell Lung Cancers (NSCLC) with EGFR mutations including Exon 20 insertions or uncommon/compound mutations.
• Deadline: March 18, 2025
  AACR-EMD "I'm IN" Oncodisparity Fellowships in Lung and Urothelial Cancers
  The AACR-EMD Serono “I’M IN” Oncodisparity Fellowships in Lung and Urothelial Cancers represent a joint effort to encourage and support postdoctoral or clinical research fellows to conduct cancer disparities research and to establish a successful career path in this field. The proposed research should specifically address disparities in oncology care in the area of non-small cell lung cancer (NSCLC) or advanced urothelial carcinoma care and address barriers leading to inequality of cancer care that exist in institutions and within society at large.